This inventor holds 1 USPTO granted patent. Top assignees: Chung Ang University Industry Academic Cooperation, Chungbuk National University Industry-Academic Cooperation Foundation, Industry Academic Cooperation Foundation Hallym University. Active years: 2015.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
1 out of 211 
1 out of 46 
1 out of 21 Years Active: 2015
Title: Kyu Wan Kim: Innovator in Corneal Endothelial Treatment
Introduction
Kyu Wan Kim is a notable inventor based in Cheongju-si, South Korea. He has made significant contributions to the field of pharmaceuticals, particularly in the treatment of corneal endothelial wounds. His innovative approach utilizes angiogenin, a protein known for its role in angiogenesis, to enhance healing processes in ocular tissues.
Latest Patents
Kyu Wan Kim holds 1 patent for his invention titled "Pharmaceutical composition for treatment of corneal endothelial wounds containing angiogenin." This patent describes a pharmaceutical composition that includes angiogenin as an effective ingredient for treating corneal endothelium wounds. The invention highlights a new topical therapeutic use of angiogenin, which activates the PI3K/Akt/eNOS pathway in ocular corneal endothelium. This activation promotes the migration and proliferation of corneal endothelial cells, which are typically incapable of self-proliferation, thereby aiding in the prevention and treatment of corneal endothelial cell wounds.
Career Highlights
Throughout his career, Kyu Wan Kim has been associated with prominent institutions that focus on academic and industrial cooperation. He has worked with Chung Ang University Industry Academic Cooperation and Chungbuk National University Industry-Academic Cooperation Foundation. His work in these institutions has allowed him to bridge the gap between research and practical applications in the pharmaceutical industry.
Collaborations
Kyu Wan Kim has collaborated with notable colleagues, including Jae Chan Kim and Kyoung Woo Kim. These partnerships have contributed to the advancement of research and development in the field of corneal treatments.
Conclusion
Kyu Wan Kim's innovative work in the pharmaceutical composition for treating corneal endothelial wounds showcases his dedication to improving ocular health. His contributions are significant in the realm of medical advancements, particularly in enhancing healing processes for corneal injuries.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile